Product
4D-110
1 clinical trial
1 indication
Indication
ChoroideremiaClinical trial
Phase 1 Open-Label, Dose-Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intravitreal 4D-110 in Patients With ChoroideremiaStatus: Active (not recruiting), Estimated PCD: 2024-06-01